Outpatient inhaled corticosteroid use in bronchopulmonary dysplasia
Pediatric Pulmonology · 2024
DOI: 10.1002/ppul.27134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, 2024. Verfasst von Cynara Leon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Sleep Medicine, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, Asthma, Adrenal Cortex Hormones. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NICHD NIH HHS, NIH HHS.
Abstract (Originalsprache)
Rationale
In the outpatient setting, inhaled corticosteroids (ICS) are frequently given to children with bronchopulmonary dysplasia (BPD) for treatment of respiratory and asthma‐associated symptoms. In this study we sought to determine if correlations existed between ICS use and ICS initiation and patient characteristics and outpatient respiratory outcomes.
Methods
This study included children with the diagnosis of BPD ( n = 661) who were seen in outpatient pulmonary clinics at the Children's Hospital of Philadelphia between 2016 and 2021. Chart review was used to determine patient demographics, use and timing of ICS initiation, asthma diagnosis, and acute care usage following initial hospital discharge.
Results
At the first pulmonary visit, 9.2% of children had been prescribed an ICS at NICU discharge, 13.9% had been prescribed an ICS after NICU discharge but before their first pulmonary appointment, and 6.9% were prescribed an ICS at the completion of initial pulmonary visit. Children started on an ICS as outpatients had a higher likelihood of ER visits (adjusted odds ratio: 2.68 ± 0.7), hospitalizations (4.81 ± 1.16), and a diagnosis of asthma (3.58 ± 0.84), compared to children never on an ICS. Of those diagnosed with asthma, children prescribed an ICS in the outpatient setting received the diagnosis at an earlier age. No associations between NICU BPD severity scores and ICS use were found.
Conclusions
This study identifies an outpatient BPD phenotype associated with ICS use and ICS initiation independent of NICU severity score. Additionally, outpatient ICS initiation correlates with a subsequent diagnosis of asthma and acute care usage in children with BPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary and Sleep Medicine, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Eudowood Division of Pediatric Respiratory Sciences, Johns Hopkins University, Baltimore, Maryland, USA.
ORCID-Profile: Cynara Leon, Jelte Kelchtermans, Joseph M Collaco, Sharon A McGrath-Morrow
Förderung
- NIEHS NIH HHS
- NICHD NIH HHS
- NIH HHS
- NHLBI NIH HHS
- Parker B Francis Foundation
Zitieren
APA
Leon, C., Martin, A., Young, L. R., Aoyama, B. C., Rice, J. L., Kelchtermans, J., Collaco, J. M., & McGrath-Morrow, S. A. (2024). Outpatient inhaled corticosteroid use in bronchopulmonary dysplasia. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27134
Vancouver
Leon C, Martin A, Young LR, Aoyama BC, Rice JL, Kelchtermans J, et al. Outpatient inhaled corticosteroid use in bronchopulmonary dysplasia. Pediatric Pulmonology. 2024. doi:10.1002/ppul.27134
BibTeX
@article{Leon2024,
author = {Leon, Cynara and Martin, Amanda and Young, Lisa R and Aoyama, Brianna C and Rice, Jessica L and Kelchtermans, Jelte and Collaco, Joseph M and McGrath-Morrow, Sharon A},
title = {Outpatient inhaled corticosteroid use in bronchopulmonary dysplasia},
journal = {Pediatric Pulmonology},
year = {2024},
doi = {10.1002/ppul.27134}
}
EUVIMED